Omnicell's (OMCL) Central Pharmacy Dispensing Service Selected by Tucson VA Medical Center
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/8/2026
- S&P 500 falls as AI worries hit software makers
- Brent crude hits six-week high near $97 as Houthi strike targets Saudi Aramco
- Qualcomm stock surges 9.5% on Amazon AI deal & 25M share warrant
- Energy stocks rise premarket as oil prices climb on Middle East supply fears
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
- Citi initiates UiPath coverage with Buy rating and $23 target
- Harry and Meghan surprised by King Charles' letter on their status
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- S&P 500 falls as AI worries hit software makers
- After an 18% summer selloff in chip stocks, Citi asks what comes next
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Omnicell (OMCL) PT Raised to $155 at Cantor Fitzgerald
November 2, 2021 11:38 AM EDTCantor Fitzgerald analyst Steven Halper raised the price target on Omnicell (NASDAQ: OMCL) to $155.00 (from $135.00) while maintaining a Neutral rating.
The analyst commented, "We reiterate our Neutral rating on OMCL shares but increase our 12-month, DCF-based price target to $155 (compared to $135 previously). This morning, November 2, the company reported 3Q21 results that were ahead of our estimates and FactSet consensus. Revenue was $296 million compared to our estimate of $284 million. Revenue... More
Omnicell (OMCL) Tops Q3 EPS by 17c
November 2, 2021 7:35 AM EDTOmnicell (NASDAQ: OMCL) reported Q3 EPS of $1.08, $0.17 better than the analyst estimate of $0.91. Revenue for the quarter came in at $296 million versus the consensus estimate of $284.74 million.
GUIDANCE:
Omnicell sees FY2021 EPS of $3.80-$3.85, versus the consensus of $3.73. Omnicell sees... More
